Actively Recruiting
Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
Led by Addpharma Inc. · Updated on 2026-02-11
46
Participants Needed
1
Research Sites
6 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.
CONDITIONS
Official Title
Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age equal to or greater than 19 years at screening
- Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at screening
You will not qualify if you...
- Use of drugs inducing or inhibiting drug-metabolizing enzymes within 30 days before study start
- Use of drugs affecting the study within 10 days before study start
- Other unspecified exclusions applied
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea
Actively Recruiting
Research Team
J
JaeHun Jung
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here